Quantity: 50 Tablets
Discover SLU-PP-332 500mcg, a synthetic small-molecule pan-agonist of the estrogen-related receptors (ERRα, ERRβ, and ERRγ). Developed as a research tool at Saint Louis University, SLU-PP-332 activates an aerobic exercise-like genetic program in skeletal muscle and has been studied extensively in rodent models for its effects on mitochondrial biogenesis, endurance capacity, energy expenditure, and metabolic parameters.
Although frequently discussed alongside research peptides, SLU-PP-332 is not a peptide — it is a low-molecular-weight organic compound. The 500mcg strength is a common research vial or aliquot size used for laboratory protocols.
Key Research Areas of Interest for SLU-PP-332 500mcg
• Induction of an ERRα-dependent aerobic exercise gene program, increasing oxidative (Type IIa) muscle fibers and enhancing treadmill endurance in untrained mice (reported increases of ~45–70% in distance/duration in key studies).
• Stimulation of mitochondrial biogenesis and fatty-acid oxidation via PGC-1α coactivation.
• Preclinical reductions in fat-mass accumulation and improvements in energy expenditure and insulin sensitivity in diet-induced obese and genetic obesity mouse models.
• Investigational effects on cardiac function in heart-failure models and age-related mitochondrial dysfunction in kidney tissue (rodent data only).
• Tool compound for studying ERR biology, mitochondrial metabolism, and potential exercise-mimetic pathways.
How SLU-PP-332 Works
SLU-PP-332 binds and activates the orphan nuclear receptors ERRα (highest potency), ERRβ, and ERRγ. Activation stabilizes coactivator recruitment (particularly PGC-1α/β), driving transcription of genes involved in:
• Mitochondrial biogenesis and oxidative phosphorylation
• Fatty-acid oxidation
• Oxidative muscle-fiber phenotype
This produces an acute “exercise-like” transcriptional response in skeletal muscle without physical activity. In published mouse studies, systemic administration increased running capacity, shifted muscle fiber composition, raised energy expenditure, and reduced fat mass accumulation without major changes in food intake.
Dosing & Research Protocol Considerations
All published efficacy and safety data come from rodent studies (typical doses in the range of 10–50 mg/kg, often intraperitoneal or oral, for periods of days to weeks). No human dose, pharmacokinetic profile, or safety data have been established. There are no registered or published human clinical trials as of the latest available information. The 500mcg research format is intended strictly for in-vitro or preclinical laboratory use.
SLU-PP-332 is not FDA-approved (or approved by any major regulatory agency) for any indication. It is sold exclusively as a research chemical.
Safety Profile
In short-term mouse studies at pharmacologically active doses, no overt toxicity, significant changes in complete blood counts, or elevations in muscle-damage markers were reported. Human safety is completely unknown. Theoretical concerns include potential off-target effects of pan-ERR activation on cardiac, bone, immune, or other tissues, as well as unknown long-term consequences of sustained mitochondrial pathway stimulation. Purity and identity of research-grade material must be verified via independent testing.
Critical Disclaimer: SLU-PP-332 500mcg is intended strictly for laboratory research purposes only. It is not a drug, dietary supplement, or approved therapeutic agent. It is not intended for human or animal consumption, self-administration, or any clinical use. This product is not intended to diagnose, treat, cure, or prevent any disease. Source only from reputable suppliers providing third-party Certificates of Analysis. Consult institutional review boards and qualified researchers for all experimental protocols. Results from animal studies do not predict human outcomes.
Support advanced ERR-pathway, mitochondrial, and exercise-mimetic research with high-purity SLU-PP-332 500mcg. Verify testing documentation and prioritize quality-sourced material for reproducible results.





Jeremy –
First time trying SLU and have to say I love it. Mental clarity, fat loss, and energy off the charts.